title: Association and management of Crohn's disease plus hidradenitis suppurativa.
authors: Carlos Henrique Marques
authors: CH
authors: dos Santos
authors: Paulo Ortiz
authors: PO
authors: Netto
authors: Karen Yumi
authors: KY
authors: Kawaguchi
authors: Jéssica Anelise
authors: JA
authors: Parreira Alves
authors: Vanessa Pereira
authors: VP
authors: de Alencar Souza
authors: Stephen
authors: S
authors: Reverdito
mesh_terms: D000038:Abscess / Q000188:drug therapy / Q000473:pathology; D000068879:Adalimumab; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D003424:Crohn Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery; D005260:Female; D017497:Hidradenitis Suppurativa / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D006801:Humans; D000069285:Infliximab; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069285:Infliximab; D000068879:Adalimumab